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Holliday junctions in DNA are generated as a product
of homologous recombination events. To test the hy-
pothesis that human p53may bind to Holliday junctions,
synthetic junctions with four ;75-base pair (Hol75) or
;565-base pair (Hol565) arms were generated. As seen by
electron microscopy, under conditions in which 50–61%
of the Hol565 DNAs were bound by p53, 80–96% of the p53
was located specifically at the junction with, in the lat-
ter case, only 4% of the p53 visualized at the DNA ends or
along the arms. Given the large number of potential
binding sites, this represents very high specificity for
the junctions. Gel retardation assays using the Hol75
DNA confirm these observations, and indicate that the
tight junction complexes have a half-life of greater than
4 h. The binding of p53 to three-way junctions is sever-
alfold less than to four-way junctions. Addition of p53
greatly increases the rate of resolution of the Hol75 DNA
by T4 endonuclease VII and T7 endonuclease I, two en-
zymes known to cleave such junctions. This latter find-
ing further confirms the interaction of p53 with Holli-
day junctions and suggests that p53 binding facilitates
their resolution in vivo.
Holliday junctions in DNA are produced by homologous re-
combination events that occur spontaneously or during the
repair of DNA damage. Recombination and thus Holliday junc-
tions are seen at high frequency in meiotic cells. In mitotic
cells, they are believed to appear in G1, and in S phase with the
repair of replication errors (1, 2). The appearance of Holliday
junctions following DNA damage is inferred from the elevated
levels of sister chromatid exchanges observed following damage
(3). If these junctions are not resolved prior to metaphase, then
during segregation, chromosomes will remain attached, result-
ing in duplication, loss, or breakage. Thus these DNA junctions
represent essential structural intermediates of homologous re-
combination, downstream products of DNA repair, and, at cer-
tain times in the cell cycle, severe lesions.
Cell cycle checkpoints exist in part to ensure that deleterious
structures in DNA are resolved or repaired prior to the cell
progressing to the next phase of the cell cycle. In higher eu-
karyotic cells, these checkpoints involve the tumor suppressor
protein p53, which has been shown to play a key role in block-
ing the cell at the G1/S border in response to DNA damage (4).
This is accomplished through transactivation of cell cycle in-
hibitors, such as p21 (5, 6). More recently p53 has also been
shown to be responsible for a G2/M block in response to dam-
age, possibly by the same mechanism involved in the p53-
induced G1/S block (7–9).
p53 also plays a role in suppressing genomic instability in
particular changes related to DNA damage. Mouse fibroblast
cells deficient in p53 show a 2-fold increase in the frequency of
UV-induced sister chromatid exchanges (10). Uncontrolled
gene amplification also appears to be kept in check by p53.
Bischoff et al. (11) observed that cultured fibroblast cells from
a Li-Fraumeni syndrome patient (loss of germ line wild type
p53) exhibit chromosome rearrangements and develop aneu-
ploidy. Furthermore, Livingstone et al. (12) noted that these
cells exhibit at least a 102-fold increase in gene amplification
events leading to the development of aneuploid cell popula-
tions, and Yin et al. (13) showed that this phenomena could be
reversed by introduction of wild type p53 in these cells.
Connections between p53 function and homologous recombi-
nation, an event likely to be closely linked to gene amplifica-
tion, have come from studies showing that wild type p53 will
down-regulate homologous recombination between SV40 mol-
ecules (14), the increase in rates of homologous recombination
in p53 mutant cell lines (15), the observation of a 39 to 59
exonuclease (16) and strand transfer (17) activities in p53, and
the demonstration that p53 will directly bind to RAD51 and
RecA proteins and, in doing so, can inhibit their function (18).
A further link between p53 and recombination may be found in
the observation of unusually high levels of p53 in certain mei-
otic cells such as those in the testes and in oocytes (19, 20).
Here the elevated levels of homologous recombination may
require higher levels of p53 to limit the extent of recombination
and to monitor the level of recombination-induced errors. If p53
is able to keep a check on deleteriously high levels of homolo-
gous recombination in vivo, then identification of which steps
or structures in DNA may be involved becomes a key question
and may be related to its ability to sense damage in DNA.
Following damage to DNA by a variety of agents including
irradiation and mutagenic drugs, the activity of p53 increases.
This increase is due in part to a prolonged half-life resulting
from post-translation modification, and in part to an increased
translation of the protein itself, but not to increased transcrip-
tion of the p53 gene (Ref. 21; reviewed in Ref. 22). The mech-
anism by which p53 signals the presence of damage in DNA has
not been fully understood, but recent work suggests that it may
in part occur at the level of direct recognition and binding of
p53 to sites of damage. Recently we showed that p53 and its
14-kDa C-terminal fragment directly recognize DNA damage in
the form of extra base bulges (insertion/deletion loop-type mis-
matches), which can arise from errors in replication or recom-
bination between sequences that are not fully homologous (23).
Additionally, Reed et al. (24) showed that p53 will bind to DNA
damaged by ionizing radiation. If p53 possesses a generalized
ability to directly sense unusual structures in DNA, then it
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seemed reasonable to ask whether it might bind to a Holliday
junction; not only are these potentially lethal structures if they
pass the G2/M border, but they also are a direct downstream
consequence of damage in DNA and represent a central inter-
mediate of homologous recombination. In this study we present
direct evidence from electron microscopy (EM)1 and biochemi-
cal assays demonstrating that p53 binds strongly to Holliday
junctions and further that this binding facilitates the resolu-
tion of such junctions in vitro by bacteriophage junction resolv-
ing enzymes.
EXPERIMENTAL PROCEDURES
Materials: DNA and Proteins
The oligonucleotides used to construct the J12 junction with 4-base
AGCC 39 overhangs were synthesized on an Applied Biosystems model
380B DNA synthesizer (Lineberger Comprehensive Cancer Center nu-
cleic acids core facility) deprotected, purified by electrophoresis in 12%
polyacrylamide gels containing 7 M urea, annealed, and electrophoresed
in 10% nondenaturing polyacrylamide gels to remove any single-strand
DNA. The addition of 538-bp duplex arms, which contain one blunt end
and one end with a GGCT 39 overhang, is described in Ref. 23. The
50-bp arms were made by direct synthesis of two complementary oligo-
nucleotides that generated a duplex with the same sequence as the first
50 bp of the 538-bp arms beginning at the overhang. The arms were
ligated to the J12 junction DNA at 21 °C for 2 h. The resulting four-
armed Holliday junction DNAs were purified by electrophoresis on
agarose or acrylamide gels. A 43-base oligonucleotide (59-CAA CGT
CAT AGA CGA TTA CAG CCA GAA TTC GGC AGC GTC AGC C-39)
was synthesized and used to generate the three-way junction DNA.
p53 protein was purified as described in Ref. 25 from nuclear extracts
prepared from Sf9 cells infected with a Autographa californica nuclear
polyhedrosis virus recombinant for the human p53 gene. The purified
protein was estimated to be greater than 90% pure as judged by Coo-
massie Blue staining on an SDS gel and Western blotting using the
monoclonal antibody 421 to p53 protein. Restriction endonucleases, T4
DNA ligase, and T4 DNA kinase were purchased from New England
Biolabs Inc. and were used according to the manufacturer’s specifica-
tions. T7 gene 5 protein with thioredoxin was the gift of Charles Rich-
ardson (Harvard University, Cambridge, MA). Bacteriophage T4 endo-
nuclease VII and T7 endonuclease I were the kind gift of Dr. Borries
Kemper (University of Koln, Koln, Germany).
Methods
Electron Microscopy—p53-DNA complexes were formed by incubat-
ing 100 ng of DNA in 50 ml of 10 mMHepes (pH 7.5), 100 mMNaCl buffer
for 20 min at 21 °C using 5 protein tetramers/junction DNA. The com-
plexes were fixed with 0.6% glutaraldehyde (v/v) for 10 min at 21 °C,
followed by filtration through 2-ml columns of Bio-Gel A5m (Bio-Rad).
To mount the DNA or the DNA-protein complexes for EM, the samples
were mixed with a buffer containing 2 mM spermidine, 2 mM MgCl2,
0.15 M NaCl, 0.10 M KCl and applied for 30 s to thin carbon foils
supported by 400-mesh copper grids. The grids were washed with a
water/ethanol series, air-dried, and rotary shadowcast at 1027 torr with
tungsten (26). Samples were examined in a Philips CM12. For publica-
tion, images were digitized using a CoHu CCD camera attached to a
Macintosh computer and the contrast adjusted using the NIH IMAGE
software. Angles formed by arms in the Holliday junction DNAs were
measured by capturing the molecule images with the CCD camera and
using routines in the NIH IMAGE software. Measurement of the pro-
jected areas of protein-DNA complexes was done by capturing the image
from the EM film with the CoHu CCD camera and using the area
measurement capability of NIH IMAGE. Mass analysis was carried out
by forming the p53-DNA complexes as described above, then mixing
them with a dilute solution of T7 gene 5 protein complexed with thi-
oredoxin (T7 DNA polymerase, 104 kDa mass) that had been fixed with
glutaraldehyde. The mixture was mounted for EM. Micrographs were
taken of fields of p53-Holliday junction complexes with the DNA polym-
erase molecules in the background. For each field, the average projected
area of the DNA polymerase molecules was determined. This was then
compared to the projected areas of the p53 Holliday junction complexes
in the same field. The mass of the p53 complexes was calculated by
multiplication of the mass of T7 DNA polymerase times the ratio of the
projected areas to the 3/2 power.
Gel Retardation Assays—For the gel retardation assays, the DNAs
were labeled with [g-32P]ATP using T4 DNA kinase and then passed
through G50 spin columns. Details of amounts of DNA, incubation
temperature, and time are in the text and figure legends. Amounts of
DNA with the same amount of radioactivity were mixed with loading
dye and electrophoresed on 4% polyacrylamide gels (19:1 acrylamide:
bisacrylamide) at 200 V at 4 °C in 0.5 3 TBE buffer until the unbound
DNAs migrated close to the bottom of the gel. The DNA was visualized
using a Molecular Dynamics PhosphorImager and direct autoradiogra-
phy using Kodak scientific imaging film. Binding buffer for p53 con-
tained 100 mM NaCl, 10 mM Hepes (pH 7.5), 10% glycerol, 100 mg/ml
BSA, 1 mM DTT, and 0.025% Nonidet P-40 to aid in stabilizing p53 at
the low protein concentrations.
Junction Cleavage by T4 Endonuclease VII and T7 Endonuclease
I—32P-Labeled Hol75 DNA was used as substrate for the junction cleav-
age assays. The DNA was incubated with amounts of enzyme and the
buffer indicated in the text at room temperature. The reactions were
stopped by adding EDTA and SDS to 50 mM and 1%, respectively, and
incubation for 5 min at 37 °C. The cleavage products were electrophore-
sed on 4% polyacrylamide gels and the DNA imaged by autoradiogra-
phy. The degree of cleavage was measured by PhosphorImager analy-
sis. One unit of T4 endonuclease VII was defined as described by
Picksley et al. (27), and 1 unit of T7 endonuclease I was set as the
cleavage activity of 1 ng of protein under these conditions.
RESULTS
Synthesis and Visualization of Synthetic Holliday Junction
DNAs with 75-bp and 565-bp Arms—DNAs with centrally lo-
cated Holliday junctions were constructed from oligonucleo-
tides based on the J12 molecule, whose physical structure and
properties have been characterized in detail (27). This junction
is able to branch migrate over a 12-bp core (see Fig. 1 in Ref.
28). In studies of the J12 and other junctions, it has been shown
that in the presence of even low concentrations of spermidine or
Mg21 ions, or relatively high Na1 ions, the junctions adopt a
stacked X configuration with the smaller angles between the
DNA arms being roughly 60°. Furthermore, with the J12 junc-
tion in the presence of Mg21 ions, the arms lie in an anti-
parallel manner and base pairing is fully preserved at the
junction as demonstrated by chemical cleavage studies (27). In
the absence of cationic metals, the junction opens into a square
configuration with the arms separated by right angles (re-
viewed in Ref. 29; see also Refs. 30–32). Here the J12 junction
was synthesized with 23–28-bp arms including a 4-base AGCC
39 overhang (termed Hol25 DNA). For the EM experiments, the
arms were extended an additional 50 or 542 bp to generate
molecules with 73–78-bp or 565–570-bp arms termed Hol75 and
Hol565 DNAs, respectively. The sequence of the arms was from
the plasmid pBR322 (see “Experimental Procedures”; see also
Ref. 23). The resulting four-armed junction DNAs separated
well away from the partial ligation products on agarose gels
with less than 5% of the DNA, as judged by EM and gel
electrophoresis, consisting of DNAs with three or fewer arms.
To attach DNA to the thin carbon foils used as EM supports
by the methods utilized here the DNA is adsorbed in the pres-
ence of a mixture of 150 mM Na1, 2 mM Mg21, and 2 mM
spermidine ions (Ref. 26; see also “Experimental Procedures”).
When the Hol565 DNA was mounted for EM in this way, exam-
ination of fields of DNAs revealed two forms (Fig. 1A). In one
form (30%), the DNA arms were arranged side-by-side and
frequently appeared wrapped about themselves. In the other
(70% n 5 179), the arms were spread apart creating an X or 1
structure. Examination of the smaller Hol75 DNAs revealed
five forms: X-shaped molecules, 1-shaped molecules, “K-
shaped” molecules (i.e. having unequal angles across the junc-
tion), Y-shaped molecules (created by two of the arms lying
side-by-side), and finally straight rods (resulting from two pairs
of arms lying side-by-side) (Fig. 1, B and C). The fraction of
molecules in each class were 14%, 8%, 6%, 43%, and 29%,
1 The abbreviations used are: EM, electron microscopy; ssDNA, single
strand DNA; CT DNA, PvuII-digested calf thymus DNA; bp, base
pair(s); BSA, bovine serum albumin; DTT, dithiothreitol.
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respectively (n 5 800); here, the DNA was adsorbed in the
presence of 20 mM Mg21 ions with no spermidine. While the
smaller angle in the X-shaped molecules was close to that of the
stacked X conformation (mean of 59 6 13 degrees; n 5 100), the
minor fraction of molecules exhibiting this form suggested that
the majority of the DNAs may have been altered by the EM
mounting procedure.
Visualization of p53 Bound to Four-way and Three-way
Junctions—To examine the binding of p53 to Holliday junc-
tions, the Hol565 DNA was incubated with human p53 produced
in insect cells (5 p53 tetramers/Holliday junction DNA) at room
temperature for 15 min in a buffer containing 100 mM NaCl.
The samples were then fixed, filtered through Bio-Gel A5m to
remove free protein and fixatives, and prepared for EM (see
“Experimental Procedures”). Examination of fields of com-
plexes (Fig. 2A) revealed a large proportion of Holliday junction
DNAs with p53 bound at the junction and no p53 bound else-
where on the DNA. Following a 20-min incubation, 49% of the
DNA molecules scored (n 5 233) had p53 bound somewhere on
the DNA, and in 80% of these molecules p53 was bound exactly
at the junction. Of the remainder, 10% contained p53 bound at
the end of an arm and another 10% had p53 bound internally
along an arm. When the incubation was extended to 30 min,
61% of the DNA molecules scored (n 5 153) showed p53 bound,
and in 96% of these molecules, p53 was bound at the junction,
and only 2% each had p53 at a DNA end or along an arm. Here
approximately two-thirds of the total p53-DNA complexes were
not in aggregates and thus could be clearly scored.
It was not possible to determine whether the distribution of
angles by which the DNA arms exited the p53 complex was
more consistent with p53 holding the junction into an open
cross (90°), a stacked X (60° and 120°) configuration, or some
other arrangement. p53 could be seen bound to the Hol75 DNA,
but only short DNA stubs exited the large protein complex
(usually tetramers and higher oligomers). Inspection of the
Hol565 DNA-p53 complexes showed no examples in which the
DNA arms were in a Y shape or lay side-by-side. Instead, the
arms were arranged into X, 1, and K structures. The angular
distributions, however, were broad and suggestive of structures
that might be intermediate between the stacked X and open
cross arrangements.
To estimate the mass of the p53 particles bound at the
junction, the projected area of the p53 complexes was compared
with that of T7 DNA polymerase (see “Experimental Proce-
dures”). This analysis showed that 6% of the junctions were
complexed by p53 monomers, 15% were bound by p53 dimers,
46% by p53 trimers or tetramers, and the remainder (33%)
contained higher oligomeric forms of p53.
It was of interest to ask whether p53 will also recognize
three-way junctions. Three-way junctions were generated us-
ing the 565-bp arms employed with the Hol565 DNAs. A sepa-
rate 43-base oligonucleotide was synthesized and annealed to
oligonucleotides 37 and 38 described in Table I of Alani et al.,
(28) used to generate the four-way junction DNAs. Following
addition of the arms and purification (see “Experimental Pro-
cedures”), the resulting three-way junction DNAs were mixed
with the Hol565 DNA in a 1:1 ratio. p53 was then added to
molar ratios of 0.5, 1.0, or 10.0 p53 tetramers/DNA. Following
a 20 min incubation at room temperature as in Fig. 2, the
fraction of three-armed or four-armed DNAs with p53 bound at
the junction was scored by EM. At a saturating level (10:1:1) of
p53, 67% (n 5 90) of the four-way junction DNA contained p53
at the junction as contrasted to 51% (n 5 134) bound to the
three-way junction DNA. Reduction of p53 to a 1:1:1 ratio
resulted in scoring 23% of the four-way junction DNA with p53
bound (n 5 100) as contrasted to 7.5% of the three-way junction
DNAs (n 5 134). Further reduction of p53 to a 0.5:1:1 ratio
resulted in 9% of the four-way junction DNAs with p53 bound
(n 5 102) as contrasted to 3% of the three-way junction DNA
(n 5 120). Thus, while saturating levels of p53 resulted in only
a 30% higher fraction of the four-way junction DNA bound by
p53, limiting concentrations of p53 resulted in a ;3-fold differ-
ence in binding affinity under identical conditions. In these
experiments the total nonspecific binding was less than 10%
that of the specific junction complexes. In the EM experiments
above with three-way and four-way junctions and with Hol75 or
Hol565 DNAs, inclusion of 2 mM Mg
21 was not found to greatly
affect p53 binding.
Gel Retardation Assays Confirm the Tight Specific Binding of
p53 to Holliday Junctions—Gel retardation assays were used
to confirm and quantify the binding of p53 to Holliday junc-
tions. Hol75 DNA (1 ng,
32P-labeled) was incubated with p53 at
molar ratios of 0, 5, 10, 20, or 40 tetramers/DNA in the pres-
ence of 100 ng of PvuII-digested calf thymus DNA (CT DNA) for
20 min at room temperature, and under three different salt
conditions: 30 mM NaCl, 130 mM NaCl, and 30 mM NaCl with 5
mM MgCl2 (Fig. 3). The sample was then electrophoresed on a
4% polyacrylamide gel (see “Experimental Procedures”). Prom-
inent retarded bands representing p53-Hol75 DNA complexes
were apparent even at the lowest molar ratio of p53 to DNA
(Fig. 3, lanes 2, 7, and 12). With increasing amounts of p53
FIG. 1. Visualization of Holliday junction DNAs. Holliday junc-
tion DNAs with arms of ;565 bp (Hol565 DNA) and ;75 bp (Hol75 DNA)
were prepared for EM by mounting onto carbon foils in the presence of
2 mM MgCl2 (A) or 20 mM MgCl2 (B and C), air-drying, and rotary
shadowcasting with tungsten (see “Experimental Procedures”). A, two
Hol565 DNAs with the arms lying side-by-side or in an X-like conforma-
tion. B and C, Hol75 DNAs in several conformations: X-shaped or square
cross-shaped molecules, Y-shaped molecules resulting from two of the
arms lying side-by-side, and rod-shaped molecules with all four arms
lying parallel. Images are shown in reverse contrast. Bar equals 500 bp
(A) and 350 bp (B and C).
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added, most of the DNA was shifted into the retarded positions
for all three salt conditions. It was noted (data not shown) that
above 300 mM NaCl, the formation of p53-Holliday junction
complexes was inhibited. Concentrations of MgCl2 above 10 mM
had a similar effect. This might reflect either a direct inhibition
of binding or the sequestering of protein or DNA into aggre-
gates. Based on the EM observations, the multiple retarded
bands likely represent different oligomeric states of p53 bound
at the junction. Incubation of the Hol75 DNA with E. coli SSB
protein, a strong single-strand DNA-binding protein at a ratio
of 10 SSB tetramers/DNA produced no significant retarded
bands as seen by autoradiography (data not shown). The
greater binding of p53 in low salt as contrasted to the two
higher salt concentrations may reflect the change in structure
of the Holliday junction that occurs between these two condi-
tions. This junction has been shown to exist in a more open
conformation in 30 mM NaCl, but a fully base-paired, stacked X
conformation in the higher salt conditions (27, 29–32) and the
latter conformation might be less effective in binding p53.
Gel retardation assays coupled with the addition of compet-
itor DNA provide a means of examining the specificity and
stability of DNA-protein complexes. Here radiolabeled Hol75
DNA (1 ng) was mixed with increasing amounts (10, 35, 60,
110, and 210 ng) of CT DNA followed by the addition of p53 (2.5
p53 tetramers/Hol75 DNA) in 10 mM Tris (pH 7.5), 5 mM MgCl2,
100 mg/ml BSA, 1 mM DTT (binding buffer) for 20 min at room
temperature and then electrophoresed. As shown in Fig. 4
(lanes 1–5), the retarded bands in the gel representing the
p53-Hol75 DNA complexes remained prominent even in the
presence of a 200-fold excess of competitor DNA (lane 5). When
unlabeled Hol75 DNA was added as a competitor (25, 50, 100, or
200 ng with in each case 10 ng of CT DNA; lanes 7–10), the
retarded bands were gradually lost, as would be expected by a
simple dilution of the probe.
To examine the stability of the specific junction complexes, 1
ng of 32P-labeled Hol75 DNA was incubated with p53 (2.5 p53
tetramers/DNA) in binding buffer with 10 ng of CT DNA for 20
min, followed by the addition of 50 ng of unlabeled Hol75 DNA
for an additional 15, 30, 60, 120, and 240 min on ice (Fig. 5A,
lanes 2–6) and then electrophoresed. As shown, ; 80% of the
p53-DNA complexes were lost after 15 min (Fig. 5A, lane 2, and
B), followed by no significant drop through 4 h, suggesting that
the tight complexes have a half-life of greater than 4 h. Bipha-
sic decay curves such as these can be interpreted in either of
two ways. First, they could result from the presence of a large
number of nonspecific complexes, for example p53 bound at the
DNA ends or along the arms which are rapidly lost upon
challenge, and a small number of resistant complexes formed
at the junction. Second, the curves could reflect two classes of
(specific) complexes formed at the Holliday junctions, one that
is highly resistant to challenge and another that is less stable
FIG. 2. Visualization of human p53
bound to Holliday junction DNAs.
Human p53 was incubated with Hol565
DNA at a molar ratio of 5 p53 tetramers/
DNA for 15–30 min at room temperature.
The complexes were then fixed and pre-
pared for EM as in Fig. 1. A, field of com-
plexes (taken at a 40° tilt to enhance con-
trast) in which 5 of the 6 Hol565 DNAs
have p53 bound specifically at the junc-
tion. B–D, individual examples (0° tilt)
with p53 bound at the junction as a dimer
(C), tetramer (B), or higher oligomer (D).
Images are shown in reverse contrast.
Bar equals 0.06 mm (A) and 0.05 mm
(B–D).
FIG. 3. Gel retardation analysis of p53-Holliday junction bind-
ing under different salt conditions. 32P-Labeled Hol75 DNA (1 ng,
0.25 nM) was incubated for 20 min at room temperature without p53
(lanes 1, 6, and 11) or with p53 protein at molar ratios of 5 (lanes 2, 7,
and 12), 10 (lanes 3, 8, and 13), 20 (lanes 4, 9, and 14), or 40 (lanes 5, 10,
and 15) p53 tetramers/DNA. The binding buffer (10 mM Tris (pH 7.5),
100 mg/ml BSA, 1 mM DTT, and 10 ng/ml PvuII-digested CT DNA) was
supplemented with 30 mM NaCl (lanes 1–5), 130 mM NaCl (lanes 6–10),
and 5 mM MgCl2 with 30 mM NaCl (lanes 11–15). The samples were
electrophoresed on 4% polyacrylamide gels and DNA imaged by auto-
radiography (see “Experimental Procedures”). The positions of free
DNA (Hol75) and p53 protein-DNA complexes (p53/DNA) are indicated.
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and more easily lost in the presence of competitor. Here, the
EM observations strongly argue for the latter interpretation
since almost all of the p53 was observed bound at the junctions.
The different oligomeric complexes of p53 at the junction, in
particular dimers and tetramers, may differ in their stability.
p53 Binding Enhances the Endonuclease-mediated Cleavage
of Holliday Junctions—The tight binding of p53 to Holliday
junctions described above could influence events of homologous
recombination, in particular at the stage of junction resolution.
A strong junction-binding protein might either sequester the
junctions from resolving enzymes or possibly expose the junc-
tions to cleavage. T4 endonuclease VII and T7 endonuclease I
represent well characterized junction resolvases (27). Both
bind such junctions specifically and cleave four-way junctions
by introducing nicks at symmetrically related positions across
the junction. Here we have examined the cleavage of Hol75
DNA by these enzymes in the presence of p53 protein. The
sequence for the core junction used here was taken from Pick-
sley et al. (27), where the cleavage of this particular junction by
these two enzymes in a reaction requiring magnesium was
characterized in detail.
Hol75 DNA (1 ng;
32P-labeled) was incubated at room tem-
perature with 1 ml of p53 storage buffer or 1 ml of p53 protein
(5 ng, 5 tetramer proteins/DNA) in a 10-ml volume of 50 mM
Tris (pH 8), 5 mM MgCl2, 1 mM DTT, 100 mg/ml BSA, and 10
mg/ml CT DNA (cleavage buffer) for 15 min, followed by the
addition of 10–90 units of T4 endonuclease VII for 15 min
more. The cleavage was stopped and the DNA electrophoresed
on a 4% polyacrylamide gel (see “Experimental Procedures”).
The Hol75 DNA was cleaved much more readily in the presence
of p53 protein as contrasted to the level of cleavage in the
absence of p53 (Fig. 6, A and B). Indeed, in the presence of p53,
10 units of T4 endonuclease VII produced at least as much
cleavage as that seen with 90 units of enzyme in the absence of
p53, a 9-fold difference. A parallel experiment was carried out
using T7 endonuclease I (1 through 5 units), with a similar
outcome (Fig. 6, C and D). Under these conditions, addition of
E. coli SSB protein in place of p53 (at the same molar ratio),
which was not found to bind the Holliday junctions, did not
alter the cleavage rates of the junctions by T4 endonuclease VII
or T7 endonuclease I (data not shown). Analysis of the cleavage
products showed that the DNA arms of the junctions migrated
to the same position in the 4% polyacrylamide gels whether or
not p53 had been present. Furthermore, analysis of the size of
the cleavage products on 6% urea denaturing gels (data not
shown) revealed no difference in size whether or not p53 was
present.
The kinetics of junction cleavage by T4 endonuclease VII was
examined in the presence or absence of p53 (Fig. 7, A and B).
Hol75 DNA (
32P-labeled; 10 ng) was incubated at room temper-
ature with p53 storage buffer or p53 protein (50 ng, 5 p53
tetramers/DNA), for 15 min followed by the addition of 2000
units of T4 endonuclease VII in a 100-ml volume of cleavage
buffer. Aliquots (10 ml) were removed between 0 and 13 min,
mixed with a stop solution, and electrophoresed on 4% poly-
acrylamide gels (see “Experimental Procedures”). After a 3-min
incubation, the overall level of cleavage in the presence of p53
was severalfold greater than in the absence of p53 (Fig. 7B).
DISCUSSION
In this study we show that human p53 binds specifically and
strongly to Holliday junctions. In one experiment, when p53
was incubated with a DNA containing a synthetic Holliday
junction flanked by four ;570-bp arms, 61% of the DNA mol-
ecules contained p53 bound and in 96% of these, the p53 was
bound exclusively at the junction. Considering the large num-
ber of potential binding sites along the length of the arms and
at the DNA ends, this represents a very high specificity for the
junction. Gel retardation assays confirm this observation, re-
veal that once formed, the specific junction complexes are rel-
atively stable to challenge by competitor DNA, and provide an
estimate of the half-life of the tight junction complexes of at
least 4 h. Binding to three-armed junctions is ;3-fold lower.
Finally, rather than protecting the junctions from nucleolytic
FIG. 4. Specificity of p53 binding to Holliday junctions. 32P-
Labeled Hol75 DNA (1 ng, 0.25 nM) was mixed with 10 ng (lanes 1 and
6–10), 35 ng (lane 2), 60 ng (lane 3), 110 ng (lane 4), and 210 ng (lane 5)
of PvuII-digested calf thymus DNA, and 25 ng (lane 7), 50 ng (lane 8),
100 ng (lane 9), and 200 ng (lane 10) of unlabeled Hol75 DNA. All
reactions were incubated with p53 protein (2.5 tetramers/labeled Hol75
DNA) in 10 mM Tris (pH 7.5), 5 mM MgCl2, 100 mg/ml BSA, 1 mM DTT
for 20 min at room temperature and the samples electrophoresed on 4%
polyacrylamide gels and the DNA imaged by autoradiography (see
“Experimental Procedures”). The positions of free DNA (Hol75) and p53
protein-DNA complexes (p53/DNA) are indicated.
FIG. 5. Stability of p53 bound to Holliday junctions. A, p53-Hol75
complexes were formed by incubating 32P-labeled Hol75 DNA (1 ng, 0.25
nM) with p53 (2.5 tetramers/DNA) under the conditions described in
Fig. 4 for 20 min at room temperature, followed by addition of 50 ng of
unlabeled Hol75 DNA. The reactions were stopped (lane 1) or incubated
on ice for an additional 15, 30, 60, 120, and 240 min (lanes 2–6). The
reactions were staged to be completed at the same time, and the sam-
ples then electrophoresed on a 4% polyacrylamide gel and the DNA
imaged by autoradiography. B, the fraction of DNA bound by p53 (%
bound) from the gel in A was measured using a Molecular Dynamics
PhosphorImager. This percentage was calculated by dividing the inten-
sity of the p53-Hol75 DNA complex bands by the total intensity (Hol75
and p53/DNA).
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attack, p53 facilitates their cleavage by T4 endonuclease VII
and T7 endonuclease I.
Holliday junctions are generated in DNA as a product of
homologous recombination events and during recombinational
repair of DNA damage. They also represent potentially lethal
structures if they pass the G2/M border. In metaphase, during
chromosome formation and segregation, a Holliday junction
could lead to chromosomes remaining paired, resulting in chro-
mosome loss, duplication, or possibly breakage. Hence it seems
reasonable that cellular mechanisms would exist to measure
the level of unresolved junctions, halt the cell cycle until this
level was appropriately low, and possibly also to facilitate their
resolution. Here we have provided direct evidence that this
may be accomplished by a p53-related pathway. Furthermore,
given the recent links that have been found between p53 ac-
tivity and homologous recombination (see Introduction and
Ref. 18), the findings presented here suggest that p53 may
function through direct binding to Holliday junctions in vivo.
The EM and biochemical data provide clues concerning the
features of the Holliday junctions recognized by p53 and the
structure of the junction following p53 binding. The images of
the Hol565 and Hol75 DNAs were consistent with a fraction of
the DNA being in the stacked X conformation under the mount-
ing conditions utilized (relatively high divalent cations and or
spermidine). However, the large fraction of molecules that were
in other structures suggests significant distortion of the DNA
upon adsorption to the support. By EM, p53 was seen to bind to
the Holliday junctions with high specificity both in the pres-
ence and absence of magnesium. This was confirmed by gel
retardation data (Fig. 3), which also pointed to a slightly
greater binding at low protein concentrations in low salt where
the DNA would exist in the more extended conformation as
contrasted to higher salt (with or without magnesium) where
the DNA would have been in the stacked X conformation. When
p53 bound to the Hol75 DNA, the large size of the p53 complex
(predominantly tetramers and octamers) obscured the angles
at which the arms exited the protein complex. In complexes
formed with the Hol565 DNA, analysis of the angles formed by
the DNA arms suggested that most fell somewhere between the
stacked X conformation (60° and 120° angles) and the extended
conformation (90° angles). Indeed, few if any molecules were
seen with the arms at 90° angles or folded on themselves (very
shallow angles). These observations are consistent with studies
by Lilley and colleagues (33, 34) on the binding of T4 endonu-
clease VII and T7 endonuclease I to four-way junctions, where
it was concluded that these enzymes hold the junction into a
with 1 ml of p53 storage buffer (lanes 1–10) or 1 ml of p53 protein (5 ng,
5 tetramer proteins/DNA, lanes 11–20) in 10 ml of cleavage buffer (see
“Experimental Procedures”) at room temperature for 15 min, and then
incubated for an additional 15 min at room temperature with 10 (lanes
2 and 12), 20 (lanes 3 and 13), 30 (lanes 4 and 14), 40 (lanes 5 and 15),
50 (lanes 6 and 16), 60 (lanes 7 and 17), 70 (lanes 8 and 18), 80 (lanes 9
and 19), and 90 (lanes 10 and 20) units of T4 endonuclease VII. The
samples were deproteinized, and the DNA electrophoresed on a 4%
polyacrylamide gel and imaged by autoradiography (see “Experimental
Procedures”). The positions of Hol75 DNA (Hol75) and the cleavage
products (product) are indicated. B, the percentage of uncleaved DNA in
the gel shown in A was measured using a Molecular Dynamics Phos-
phorImager and was calculated by dividing the intensity of Hol75 DNA
by the total intensity (Hol75 plus product). Closed circles, no p53 added;
open circles, with p53. C, a parallel experiment to that described in A
and B was carried out using 1 (lanes 2 and 8), 2 (lanes 3 and 9), 3 (lanes
4 and 10), 4 (lanes 5 and 11), and 5 (lanes 6 and 12) units of T7
endonuclease I without p53 (lanes 1–6) or preincubated with p53 as in
A and B (lanes 7–12). The positions of Hol75 DNA (Hol75) and the
cleavage products (product) are indicated. D, the percentage of un-
cleaved DNA in the gel shown in C was measured and plotted as
described in B. Closed circles, with p53; opened circles, no p53.
FIG. 6. p53 binding to Holliday junction can enhance the junc-
tion cleavage. A, 32P-labeled Hol75 DNA (1 ng, 0.25 nM) was incubated
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form that is between the stacked X and open cross structures
and that the structure of the resulting complexes are independ-
ent of magnesium. Further detailed analysis will be required to
eucidate how p53 facilitates the resolution of the junctions by
the T4 and T7 endonucleases. Presumably cleavage occurs
while p53 is bound, and it seems likely that p53 may partially
open the junction exposing single-strand regions to the
endonucleases.
Although the EM experiments do not provide a quantitative
measure of binding affinities of p53 to the Holliday junctions,
comparison with other experiments is informative. In Lee et al.
(23), molar ratios of p53 to DNA similar to those used here were
employed to examine the binding of p53 to 1.1-kilobase pair
DNAs containing extra base bulges. Comparison with those
results shows that a 3-fold higher fraction of the Hol565 DNA
contained p53 bound at the Holliday junction as contrasted to
a centrally located 3-cytosine bulge in the 1.1-kilobase pair
DNA. Finally, in a study of yeast MSH2 binding to Holliday
junctions (28), the same preparations of Hol565 DNA were
employed under roughly similar protein to DNA molar ratios
and incubation conditions. Comparison reveals a ;3-fold
higher fraction of Hol565 DNAs containing p53 at the junction
as contrasted to MSH2.
Although our observation that p53 binds Holliday junctions
tightly suggested that it might protect them from cleavage, it
was found to facilitate their resolution. The combination of
these two activities could strongly limit the number and extent
of recombinational junctions in vivo. This conclusion is bol-
stered by the observation that the C-terminal domain of p53
has anti-helicase activity (17, 35), a function that might slow
the progress of branch migration. Beyond maintaining a check
on the level of normal recombinational events, these activities
of p53 could be particularly important in homeologous recom-
bination between more distantly related sequences. Here, the
recombination products will contain numerous insertion/dele-
tion mismatches that would present additional targets for p53,
which could further aid in targeting p53 to the region of the
junction. The involvement of p53 with recombinational inter-
mediates may share features with that of MSH2, a protein in
the postreplication mismatch repair pathway that plays a piv-
otal role in the recognition of mismatches and which has been
recently shown to bind Holliday junctions (28). Several studies
have suggested that the mismatch repair proteins may have a
role in recombination, including suppressing homeologous re-
combination, inhibiting the formation of recombinational inter-
mediates containing too many mismatches, and possibly aiding
in the resolution of Holliday junctions (reviewed in Ref. 29). In
these reactions MSH2 appears to interact with other members
of the mismatch repair family including MSH3 and MSH6 (36).
In binding to Holliday junctions in vivo, p53 must come in
contact with a multitude of proteins including those that cat-
alyze recombination, those that resolve junctions, and others
known to bind Holliday junctions such as HMG1 (37). Indeed
p53 has been shown to directly bind to two proteins that cata-
lyze homologous recombination, hRad 51 and RPA, and to the
transcription factor TFIIH also involved in repair (18, 35, 38,
39). In the future it will be essential to learn how p53 interacts
with these proteins at a Holliday junction.
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